LINC01116 promotes the progression of papillary thyroid carcinoma by regulating the apoptosis of bone marrow mesenchymal stem cells.

He H, Liu K

Open source

DOI
10.36721/pjps/2026.40.15840.1
Published
2027 Jan 1
Container
Pakistan journal of pharmaceutical sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.36721/pjps/2026.40.15840.1,
  title = {LINC01116 promotes the progression of papillary thyroid carcinoma by regulating the apoptosis of bone marrow mesenchymal stem cells.},
  author = {He H and Liu K},
  year = {2027},
  journal = {Pakistan journal of pharmaceutical sciences},
  doi = {10.36721/pjps/2026.40.15840.1},
  url = {https://doi.org/10.36721/pjps/2026.40.15840.1}
}

RIS

TY  - JOUR
TI  - LINC01116 promotes the progression of papillary thyroid carcinoma by regulating the apoptosis of bone marrow mesenchymal stem cells.
AU  - He H
AU  - Liu K
PY  - 2027
JO  - Pakistan journal of pharmaceutical sciences
DO  - 10.36721/pjps/2026.40.15840.1
UR  - https://doi.org/10.36721/pjps/2026.40.15840.1
ER  - 

APA

H, H., & K, L. (2027). LINC01116 promotes the progression of papillary thyroid carcinoma by regulating the apoptosis of bone marrow mesenchymal stem cells.. Pakistan journal of pharmaceutical sciences. https://doi.org/10.36721/pjps/2026.40.15840.1

Source records